shortage semaglutide The weight loss drug is over — and some patients are 'panicking' Makers of compounded Wegovy, Ozempic

Noom, best-known for its weight loss app and more recent GLP-1 offering, launched an HRT program for menopause in late February, and telehealth company Hims & Hers plans to roll out at-home testing over the next year to enable care for low testosterone, perimenopause, and menopause

it has been hypothesised to complement GLP-1 activity, though evidence in humans remains limited

doi: 10.1016/j.ejim.2020.09.001

While it doesn't predict exact treatment duration, it reveals whether you're genetically predisposed to strong semaglutide response, helping your care team set realistic expectations and potentially suggesting alternative or complementary therapies

Nutrition Coaching Included: Structured meal planning and habit support

If GLP-1 Drugs Are Good For Everything, Should We All Be on Them